ID

41618

Descripción

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 14.10.2020, 15:07:14 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS is mandated by the ESCMID Emerging Infections Task Force (EITaF) and supported by the German Infectious Disease Society. It aims at a better understanding of the implications of the new virus on patients by systematically documenting patient data across Europe (Text adapted from leoss.net). For more information please visit the official website. This document is for HIV-related baseline data. All questions refer to the day of diagnosis (diagnosis means first positive virus result). Please note that only cases with known outcome are collected at LEOSS! If a text field can't be filled out, note 'ND' (for not determined).

Link

https://leoss.net

Palabras clave

Versiones (3)
  1. 13/11/20 13/11/20 -
  2. 27/11/20 27/11/20 -
  3. 24/4/21 24/4/21 -
Titular de derechos de autor

LEOSS

Subido en

27 de noviembre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Inglés

HIV-related baseline data

1 formularios  
HIV transmission risk
Descripción

HIV transmission risk

Alias
UMLS CUI-1
C0019682
UMLS CUI-2
C0035648
UMLS CUI-3
C1443844
Men having sex with men
Descripción

Men having sex with men

Tipo de datos

integer

Alias
UMLS CUI [1]
C2827413
Heterosexual contacts
Descripción

Heterosexual contacts

Tipo de datos

integer

Alias
UMLS CUI [1]
C4272228
Injection drug use
Descripción

Injection drug use

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0281875
UMLS CUI [1,2]
C1272883
UMLS CUI [2,1]
C0086190
UMLS CUI [2,2]
C1272883
Patient from an endemic area
Descripción

Patient from HIV endemic area

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C3258107
UMLS CUI [1,2]
C0277550
UMLS CUI [1,3]
C0019682
Blood transfusion (excl. Haemophilia)
Descripción

Blood transfusion (excl. Haemophilia)

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0005841
UMLS CUI [1,2]
C1705847
UMLS CUI [1,3]
C0684275
Haemophilia
Descripción

Haemophilia

Tipo de datos

integer

Alias
UMLS CUI [1]
C0684275
Other
Descripción

Other HIV transmission risk

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
If Other, please specify:
Descripción

Other HIV transmission risk, specify

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C1521902
Unknown
Descripción

Unknown HIV transmission risk

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0439673
UMLS CUI [1,2]
C0035648
UMLS CUI [1,3]
C1443844
UMLS CUI [1,4]
C0205394
Does the patient receive current antiretroviral therapy?
Descripción

Does the patient receive current antiretroviral therapy?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C0521116
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
Descripción

Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0162714
UMLS CUI [2]
C0674432
UMLS CUI [3]
C0292818
UMLS CUI [4]
C1435444
UMLS CUI [5]
C1145759
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Descripción

Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0376601
UMLS CUI [2]
C1871526
UMLS CUI [3]
C3253985
UMLS CUI [4]
C4507568
UMLS CUI [5]
C2606637
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Descripción

Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1]
C3541376
UMLS CUI [2]
C0674428
UMLS CUI [3]
C0132326
UMLS CUI [4]
C1566826
UMLS CUI [5]
C4045491
Nucleoside analog reverse-transcriptase inhibitors
Descripción

Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1]
C3537103
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
Descripción

Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

Tipo de datos

integer

Alias
UMLS CUI [1]
C1449715
UMLS CUI [2]
C1667052
UMLS CUI [3]
C0537439
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
Descripción

In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C0449238
UMLS CUI-3
C0332152
UMLS CUI-4
C5203676
UMLS CUI-5
C1511790
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
Descripción

Note: This question is critical for the further course of the questionnaire. Please indicate the number of months antiretroviral therapy had been taken.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
Descripción

Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C3665894
UMLS CUI-3
C1704686
UMLS CUI-4
C0347984
UMLS CUI-5
C5203670
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
Descripción

Note: This question is critical for the further course of the questionnaire.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C3665894
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C5203670
UMLS CUI [2,1]
C1963724
UMLS CUI [2,2]
C1704686
UMLS CUI [2,3]
C0347984
UMLS CUI [2,4]
C5203670
Please indicate the regimen at the end of the follow-up period
Descripción

Please indicate the regimen at the end of the follow-up period

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C1276413
UMLS CUI-3
C1522577
UMLS CUI-4
C0444930
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
Descripción

Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1]
C0162714
UMLS CUI [2]
C0674432
UMLS CUI [3]
C0292818
UMLS CUI [4]
C1435444
UMLS CUI [5]
C1145759
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Descripción

Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1]
C0376601
UMLS CUI [2]
C1871526
UMLS CUI [3]
C3253985
UMLS CUI [4]
C4507568
UMLS CUI [5]
C2606637
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Descripción

Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1]
C3541376
UMLS CUI [2]
C0674428
UMLS CUI [3]
C0132326
UMLS CUI [4]
C1566826
UMLS CUI [5]
C4045491
Nucleoside analog reverse-transcriptase inhibitors
Descripción

Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1]
C3537103
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
Descripción

Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

Tipo de datos

integer

Alias
UMLS CUI [1]
C1449715
UMLS CUI [2]
C1667052
UMLS CUI [3]
C0537439
CD4+ T-cell count (abs.)
Descripción

CD4+ T-cell count (abs.)

Alias
UMLS CUI-1
C1277776
Before diagnosis
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
Baseline (at first positive SARS-CoV-2 testing)
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C5203676
UMLS CUI [2,2]
C1511790
Uncomplicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
Complicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
Critical phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
Recovery phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277776
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
CD4+ T-cell count (rel.)
Descripción

CD4+ T-cell count (rel.)

Alias
UMLS CUI-1
C2698595
UMLS CUI-2
C0205345
Before diagnosis
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
Baseline (at first positive SARS-CoV-2 testing)
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1442488
UMLS CUI [2,1]
C5203676
UMLS CUI [2,2]
C1511790
Uncomplicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Complicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0231242
UMLS CUI [1,4]
C0205390
Critical phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1511545
UMLS CUI [1,4]
C0205390
Recovery phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698595
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C2004454
UMLS CUI [1,4]
C0205390
Please indicate the CDC stage at baseline
Descripción

Please indicate the CDC stage at baseline

Alias
UMLS CUI-1
C1272816
Please indicate the CDC stage at baseline
Descripción

Note: This question is critical for the further course of the questionnaire. CDC stages are mainly defined by CD4 count (see figure on the following website), or stage-3-defining illness which can be revised at https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm?s_cid=rr6303a1_e

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1272816
UMLS CUI [1,2]
C1442488
CD8+ T-cell count (abs.)
Descripción

CD8+ T-cell count (abs.)

Alias
UMLS CUI-1
C1277777
Before diagnosis
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
Baseline (at first positive SARS-CoV-2 testing)
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C5203676
UMLS CUI [2,2]
C1511790
Uncomplicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
Complicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
Critical phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
Recovery phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277777
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
CD8+ T-cell count (rel.)
Descripción

CD8+ T-cell count (rel.)

Alias
UMLS CUI-1
C2698600
UMLS CUI-2
C0205345
Before diagnosis
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
Baseline (at first positive SARS-CoV-2 testing)
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1442488
UMLS CUI [2,1]
C5203676
UMLS CUI [2,2]
C1511790
Uncomplicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0443334
UMLS CUI [1,4]
C0205390
Complicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C0231242
UMLS CUI [1,4]
C0205390
Critical phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C1511545
UMLS CUI [1,4]
C0205390
Recovery phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2698600
UMLS CUI [1,2]
C0205345
UMLS CUI [1,3]
C2004454
UMLS CUI [1,4]
C0205390
Viral load
Descripción

Viral load

Alias
UMLS CUI-1
C1168369
Before diagnosis
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
Baseline (at first positive SARS-CoV-2 testing)
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C5203676
UMLS CUI [2,2]
C1511790
Uncomplicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0443334
UMLS CUI [1,3]
C0205390
Complicated phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C0231242
UMLS CUI [1,3]
C0205390
Critical phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C1511545
UMLS CUI [1,3]
C0205390
Recovery phase
Descripción

Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1168369
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C0205390
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
Descripción

Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?

Alias
UMLS CUI-1
C0029118
UMLS CUI-2
C0740830
UMLS CUI-3
C0036916
UMLS CUI-4
C5203670
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
Descripción

Note: This question is critical for the further course of the questionnaire.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0029118
UMLS CUI [1,2]
C5203670
UMLS CUI [2,1]
C0740830
UMLS CUI [2,2]
C5203670
UMLS CUI [3,1]
C0036916
UMLS CUI [3,2]
C5203670
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection? If Yes, please specify:
Descripción

Note: This question is critical for the further course of the questionnaire.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0029118
UMLS CUI [1,2]
C5203670
UMLS CUI [2,1]
C0740830
UMLS CUI [2,2]
C5203670
UMLS CUI [3,1]
C0036916
UMLS CUI [3,2]
C5203670
UMLS CUI [4]
C1521902
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197
Volver a la parte superior de la página

Similar models

HIV-related baseline data

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
HIV transmission risk
C0019682 (UMLS CUI-1)
C0035648 (UMLS CUI-2)
C1443844 (UMLS CUI-3)
Item
Men having sex with men
integer
C2827413 (UMLS CUI [1])
Men having sex with men
Code List
Men having sex with men
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Heterosexual contacts
integer
C4272228 (UMLS CUI [1])
Men having sex with men
Code List
Heterosexual contacts
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Injection drug use
integer
C0281875 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0086190 (UMLS CUI [2,1])
C1272883 (UMLS CUI [2,2])
Men having sex with men
Code List
Injection drug use
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Patient from an endemic area
integer
C3258107 (UMLS CUI [1,1])
C0277550 (UMLS CUI [1,2])
C0019682 (UMLS CUI [1,3])
Men having sex with men
Code List
Patient from an endemic area
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Blood transfusion (excl. Haemophilia)
integer
C0005841 (UMLS CUI [1,1])
C1705847 (UMLS CUI [1,2])
C0684275 (UMLS CUI [1,3])
Men having sex with men
Code List
Blood transfusion (excl. Haemophilia)
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Haemophilia
integer
C0684275 (UMLS CUI [1])
Men having sex with men
Code List
Haemophilia
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Other
integer
C0019682 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Men having sex with men
Code List
Other
CL Item
not quoted (0)
CL Item
quoted (1)
Item
If Other, please specify:
integer
C0019682 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521902 (UMLS CUI [1,5])
Men having sex with men
Code List
If Other, please specify:
CL Item
not quoted (0)
CL Item
quoted (1)
Item
Unknown
integer
C0439673 (UMLS CUI [1,1])
C0035648 (UMLS CUI [1,2])
C1443844 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Men having sex with men
Code List
Unknown
CL Item
not quoted (0)
CL Item
quoted (1)
Item Group
Does the patient receive current antiretroviral therapy?
C1963724 (UMLS CUI-1)
C0521116 (UMLS CUI-2)
Item
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
integer
C0162714 (UMLS CUI [1])
C0674432 (UMLS CUI [2])
C0292818 (UMLS CUI [3])
C1435444 (UMLS CUI [4])
C1145759 (UMLS CUI [5])
Gender
Code List
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
integer
C0376601 (UMLS CUI [1])
C1871526 (UMLS CUI [2])
C3253985 (UMLS CUI [3])
C4507568 (UMLS CUI [4])
C2606637 (UMLS CUI [5])
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Code List
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
integer
C3541376 (UMLS CUI [1])
C0674428 (UMLS CUI [2])
C0132326 (UMLS CUI [3])
C1566826 (UMLS CUI [4])
C4045491 (UMLS CUI [5])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Nucleoside analog reverse-transcriptase inhibitors
integer
C3537103 (UMLS CUI [1])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Nucleoside analog reverse-transcriptase inhibitors
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
integer
C1449715 (UMLS CUI [1])
C1667052 (UMLS CUI [2])
C0537439 (UMLS CUI [3])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
C1963724 (UMLS CUI-1)
C0449238 (UMLS CUI-2)
C0332152 (UMLS CUI-3)
C5203676 (UMLS CUI-4)
C1511790 (UMLS CUI-5)
Item
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
integer
C1963724 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
undefined item
Code List
In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
CL Item
< 3 months (1)
CL Item
3 - 6 months (2)
CL Item
> 6 months (3)
CL Item
Unknown (4)
CL Item
No antiretroviral therapy (5)
Item Group
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
C1963724 (UMLS CUI-1)
C3665894 (UMLS CUI-2)
C1704686 (UMLS CUI-3)
C0347984 (UMLS CUI-4)
C5203670 (UMLS CUI-5)
Item
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
integer
C1963724 (UMLS CUI [1,1])
C3665894 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C5203670 (UMLS CUI [1,4])
C1963724 (UMLS CUI [2,1])
C1704686 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C5203670 (UMLS CUI [2,4])
undefined item
Code List
Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Please indicate the regimen at the end of the follow-up period
C1963724 (UMLS CUI-1)
C1276413 (UMLS CUI-2)
C1522577 (UMLS CUI-3)
C0444930 (UMLS CUI-4)
Item
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
integer
C0162714 (UMLS CUI [1])
C0674432 (UMLS CUI [2])
C0292818 (UMLS CUI [3])
C1435444 (UMLS CUI [4])
C1145759 (UMLS CUI [5])
Gender
Code List
Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
integer
C0376601 (UMLS CUI [1])
C1871526 (UMLS CUI [2])
C3253985 (UMLS CUI [3])
C4507568 (UMLS CUI [4])
C2606637 (UMLS CUI [5])
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
Code List
Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
integer
C3541376 (UMLS CUI [1])
C0674428 (UMLS CUI [2])
C0132326 (UMLS CUI [3])
C1566826 (UMLS CUI [4])
C4045491 (UMLS CUI [5])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Nucleoside analog reverse-transcriptase inhibitors
integer
C3537103 (UMLS CUI [1])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Nucleoside analog reverse-transcriptase inhibitors
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
integer
C1449715 (UMLS CUI [1])
C1667052 (UMLS CUI [2])
C0537439 (UMLS CUI [3])
Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
Code List
Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
CD4+ T-cell count (abs.)
C1277776 (UMLS CUI-1)
Item
Before diagnosis
integer
C1277776 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
Before diagnosis
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Baseline (at first positive SARS-CoV-2 testing)
integer
C1277776 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
Before SARS-CoV-2 detection
Code List
Baseline (at first positive SARS-CoV-2 testing)
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Uncomplicated phase
integer
C1277776 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
Uncomplicated phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Complicated phase
integer
C1277776 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
Complicated phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Critical phase
integer
C1277776 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
Critical phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Recovery phase
integer
C1277776 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
Before SARS-CoV-2 detection
Code List
Recovery phase
CL Item
< 200 Cells / µL (1)
CL Item
200-500 Cells / µL (2)
CL Item
> 500 Cells / µL (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
CD4+ T-cell count (rel.)
C2698595 (UMLS CUI-1)
C0205345 (UMLS CUI-2)
Item
Before diagnosis
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
Before SARS-CoV-2 detection
Code List
Before diagnosis
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Baseline (at first positive SARS-CoV-2 testing)
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C5203676 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
Before SARS-CoV-2 detection
Code List
Baseline (at first positive SARS-CoV-2 testing)
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Uncomplicated phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
Uncomplicated phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Complicated phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0231242 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
Complicated phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Critical phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1511545 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
Critical phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Recovery phase
integer
C2698595 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
Before SARS-CoV-2 detection
Code List
Recovery phase
CL Item
< 14 % (1)
CL Item
14 - 25 % (2)
CL Item
> 25 % (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
Please indicate the CDC stage at baseline
C1272816 (UMLS CUI-1)
Item
Please indicate the CDC stage at baseline
integer
C1272816 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
HIV CDC stage at baseline
Code List
Please indicate the CDC stage at baseline
CL Item
Stage 1 (1)
CL Item
Stage 2 (2)
CL Item
Stage 3 (3)
CL Item
Unknown (4)
Item Group
CD8+ T-cell count (abs.)
C1277777 (UMLS CUI-1)
Item
Before diagnosis
integer
C1277777 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (abs): Before SARS-CoV-2 detection
Code List
Before diagnosis
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Baseline (at first positive SARS-CoV-2 testing)
integer
C1277777 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
CD8+ (abs): Baseline (at SARS-CoV-2 detection)
Code List
Baseline (at first positive SARS-CoV-2 testing)
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Uncomplicated phase
integer
C1277777 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Uncomplicated phase
Code List
Uncomplicated phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Complicated phase
integer
C1277777 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Complicated phase
Code List
Complicated phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Critical phase
integer
C1277777 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Critical phase
Code List
Critical phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Recovery phase
integer
C1277777 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (abs): Recovery phase
Code List
Recovery phase
CL Item
< 250 cells / μl (1)
CL Item
250 - 1000 cells / μl (2)
CL Item
> 1000 cells / μl (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
CD8+ T-cell count (rel.)
C2698600 (UMLS CUI-1)
C0205345 (UMLS CUI-2)
Item
Before diagnosis
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
CD8+ (rel): Before SARS-CoV-2 detection
Code List
Before diagnosis
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Baseline (at first positive SARS-CoV-2 testing)
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C5203676 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
Code List
Baseline (at first positive SARS-CoV-2 testing)
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Uncomplicated phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0443334 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Uncomplicated phase
Code List
Uncomplicated phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Complicated phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C0231242 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Complicated phase
Code List
Complicated phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Critical phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C1511545 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Critical phase
Code List
Critical phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item
Recovery phase
integer
C2698600 (UMLS CUI [1,1])
C0205345 (UMLS CUI [1,2])
C2004454 (UMLS CUI [1,3])
C0205390 (UMLS CUI [1,4])
CD8+ (rel): Recovery phase
Code List
Recovery phase
CL Item
< 15 % (1)
CL Item
15 - 40 % (2)
CL Item
> 40 %  (3)
CL Item
Unknown (4)
CL Item
Not done (5)
Item Group
Viral load
C1168369 (UMLS CUI-1)
Item
Before diagnosis
integer
C1168369 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CD8+ (rel): Before SARS-CoV-2 detection
Code List
Before diagnosis
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
Baseline (at first positive SARS-CoV-2 testing)
integer
C1168369 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C5203676 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
CD8+ (rel): Baseline (at SARS-CoV-2 detection)
Code List
Baseline (at first positive SARS-CoV-2 testing)
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
Uncomplicated phase
integer
C1168369 (UMLS CUI [1,1])
C0443334 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Uncomplicated phase
Code List
Uncomplicated phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
Complicated phase
integer
C1168369 (UMLS CUI [1,1])
C0231242 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Complicated phase
Code List
Complicated phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
Critical phase
integer
C1168369 (UMLS CUI [1,1])
C1511545 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Critical phase
Code List
Critical phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item
Recovery phase
integer
C1168369 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
CD8+ (rel): Recovery phase
Code List
Recovery phase
CL Item
< 50 copies / ml (1)
CL Item
>= 50 copies / ml (2)
CL Item
Unknown (3)
CL Item
Not done (4)
Item Group
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
C0029118 (UMLS CUI-1)
C0740830 (UMLS CUI-2)
C0036916 (UMLS CUI-3)
C5203670 (UMLS CUI-4)
Item
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
integer
C0029118 (UMLS CUI [1,1])
C5203670 (UMLS CUI [1,2])
C0740830 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0036916 (UMLS CUI [3,1])
C5203670 (UMLS CUI [3,2])
Opportunistic infections, AIDS-defining illnesses, STI during SARS-CoV-2
Code List
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
CL Item
Yes, please sepcify (1)
CL Item
No (2)
CL Item
Unknown (3)
Opportunistic infections, AIDS-defining illnesses, STI during COVID-19 - specify
Item
Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection? If Yes, please specify:
text
C0029118 (UMLS CUI [1,1])
C5203670 (UMLS CUI [1,2])
C0740830 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0036916 (UMLS CUI [3,1])
C5203670 (UMLS CUI [3,2])
C1521902 (UMLS CUI [4])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Item
Is data entry for this section finished?
integer
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
BL_Completed
Code List
Is data entry for this section finished?
CL Item
Yes (1)
CL Item
No (2)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial